Presentations & Publications

Investors & Media

Events & Presentations

Financials & Filings

Corporate Governance

Investor Resources

Media Resources

Publication

ACR 2022 Poster 1099: PsA Phase 2 Patient Reported Outcomes, November 2022

November 29, 2022

ACR 2022 Poster 1099: PsA Phase 2 Patient Reported Outcomes, November 2022

Building an innovative biopharma company that invests in, develops and commercializes life-changing drug therapies.

Get company updates to your inbox

Sitemap

About Science Community Investors & Media Careers Stories Contact Us

Headquarters

4149 Liberty Canyon Rd

Agoura Hills, CA 91301

South San Francisco Office

701 Gateway Blvd, Suite 300

South San Francisco, CA 94080

^©2024 ACELYRIN, INC. All Rights Reserved. | ACELYRIN and the ACELYRIN logo are trademarks of ACELYRIN, INC.

Privacy Policy|Terms|